dddmag.com
Drug Discovery & Development  
  NEWSLETTERS      |      WHITE PAPERS      |      SUBSCRIBE      |      ADVERTISE      |      CONTACT US      |      ABOUT US    

  Today is: 

News
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News






SITE SPONSORS 
Advertise with Us
 

Browse Drug Development News:


NephRx's NX001 Granted Orphan Drug Status
NephRx Corporation announced that the U.S. Food and Drug Administration has granted orphan drug designation to its lead product NX001 for the prevention of delayed graft function in renal transplant recipients.  continue



 FDA Approves Abbott sNDA
Abbott announced that the U.S. Food and Drug Administration approved the supplemental New Drug Application for CREON Delayed-Release Capsules that now includes dosing guidance specific to patients with exocrine pancreatic insufficiency.  continue



 Xenon Starts Phase 2 Trial for XEN402
Xenon Pharmaceuticals Inc. announced that it has initiated a phase 2 clinical trial evaluating its novel topical XEN402 therapy for the treatment of postherpetic neuralgia.  continue



 XOMA Sells Stake in CIMZIA to Fund XOMA 052
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has sold its royalty interest in CIMZIA marketed by UCB S.A. for $4 million to an undisclosed buyer.  continue



 Tanner Signs Distribution Deal for MDR-TB Drug
Tanner Pharmaceuticals Inc. announced that it has entered into an exclusive agreement with the Chao Center for the rights to distribute cycloserine, a drug to treat multidrug-resistant tuberculosis, in the Latin American market.  continue



 Jazz Pharma Drug Treats Fibromyalgia
Shares of Jazz Pharmaceuticals Inc. jumped after federal health officials said one of its drugs appears effective for treating a chronic pain disorder.  continue
Matthew Perrone


Lilly Halts Disappointing Alzheimer's Treatment
Drugmaker Eli Lilly and Co. has stopped developing a potential Alzheimer's disease treatment in late-stage testing after patients taking the drug fared worse than those on a placebo.  continue



 FDA Questions Expanded Cymbalta Use
Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain.  continue
Matthew Perrone


Pfizer Granted Approval For New XYNTHA Delivery Method
Pfizer Inc. announced that the U.S. Food and Drug Administration has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients.  continue



 Antidepressant Helps Treat Menopausal Depression
A recently released double-blind trial showed that the antidepressant Pristiq can alleviate symptoms of major depression in women experiencing or about to experience menopause.  continue



Most Popular


  1. New Targets, Dual Agonists Increase Possibilities for Treating Diabetes

  2. New Research May Impact Treatment of MS

  3. Study Demonstrates Benefits of Cannabis for Pain

  4. Lilly Halts Disappointing Alzheimer's Treatment

  5. Jazz Pharma Drug Treats Fibromyalgia

  6. Berries Activate Brain's Housekeeping Mechanism

  7. Obama Stem Cell Regulations Temporarily Blocked

  8. J&J Appoints Quality Czar

  9. Botox Case Settled for $600M

  10. More Problems At J&J Subsidiary